Device
Single vision spectacle lenses
Single vision spectacle lenses is a medical device with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Active, not recruiting1
Enrolling by invitation1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
active_not_recruiting133%
enrolling_by_invitation133%
not_yet_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
enrolling_by_invitationnot_applicable
Management of Myopia in University Students With DIMS-TED Spectacle Lenses
NCT07679477
active_not_recruitingnot_applicable
Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control
NCT06358755
not_yet_recruitingnot_applicable
Evaluation of the Efficacy of Red Light in Adult Patients With High and Extreme Myopia
NCT07412678
Clinical Trials (3)
Showing 3 of 3 trials
NCT07679477Not Applicable
Management of Myopia in University Students With DIMS-TED Spectacle Lenses
NCT06358755Not Applicable
Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control
NCT07412678Not Applicable
Evaluation of the Efficacy of Red Light in Adult Patients With High and Extreme Myopia
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3